Sebastian-delaCruz, M.;                     Olazagoitia-Garmendia, A.;                     Gonzalez-Moro, I.;                     Santin, I.;                     Garcia-Etxebarria, K.;                     Castellanos-Rubio, A.    
        Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease. Epigenomes 2020, 4, 16.
    https://doi.org/10.3390/epigenomes4030016
    AMA Style
    
                                Sebastian-delaCruz M,                                 Olazagoitia-Garmendia A,                                 Gonzalez-Moro I,                                 Santin I,                                 Garcia-Etxebarria K,                                 Castellanos-Rubio A.        
                Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease. Epigenomes. 2020; 4(3):16.
        https://doi.org/10.3390/epigenomes4030016
    
    Chicago/Turabian Style
    
                                Sebastian-delaCruz, Maialen,                                 Ane Olazagoitia-Garmendia,                                 Itziar Gonzalez-Moro,                                 Izortze Santin,                                 Koldo Garcia-Etxebarria,                                 and Ainara Castellanos-Rubio.        
                2020. "Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease" Epigenomes 4, no. 3: 16.
        https://doi.org/10.3390/epigenomes4030016
    
    APA Style
    
                                Sebastian-delaCruz, M.,                                 Olazagoitia-Garmendia, A.,                                 Gonzalez-Moro, I.,                                 Santin, I.,                                 Garcia-Etxebarria, K.,                                 & Castellanos-Rubio, A.        
        
        (2020). Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease. Epigenomes, 4(3), 16.
        https://doi.org/10.3390/epigenomes4030016